Corporate Membership of the Association for Clinical Data Management was recently launched. For a fixed annual subscription the corporate membership allows you to obtain the following benefits:
recognition as a Member Company of the ACDM
unlimited number of individual ACDM members at a single location of your organisation
add/remove members using our online Membership Management Area
reduced prices for attending training courses and the Annual Conference
free online listing of your organisation on the ACDM website
We want survival in the UK to be among the best in the world. We’re focusing our efforts in four key areas – working to help prevent cancer, diagnose it earlier, develop new treatments and optimise current treatments by personalising them and making them even more effective.
We’ll continue to support research into all types of cancer and across all age groups. And we’re keeping our focus on understanding the biology of cancer so we can use this vital knowledge to save more lives.
We’re increasing our research in key areas such as early diagnosis, and hard-to-treat cancers including lung, pancreatic, oesophageal cancers and brain tumours.
We’re developing new tests, surgery and radiotherapy techniques, and cancer drugs. We want to personalise prevention, screening and treatment and bring benefits to patients sooner.
To help accelerate progress, we’ll be investing an additional £50 million a year into new funding schemes for our researchers. These will encourage collaboration and innovation, and support research tackling some of the biggest scientific challenges in cancer research.
Smoking is the biggest preventable cause of cancer and we’ll work towards the day when no one in the UK smokes – in particular by protecting children and helping people to quit.
We’ll campaign for the best cancer services in all parts of the UK, and give more people the chance to join the fight against cancer.
But we can’t achieve our mission alone. We rely on our dedicated scientists, doctors and nurses, and the generosity of our supporters across the UK. With your help, we can beat cancer sooner.
The Derby Clinical Trials Support Unit is fully registered by the UKCRC CTU Network. We provide a bespoke service to researchers, sponsors and industry partners – including small and medium enterprises – through the design, delivery, analysis and reporting of high quality clinical research.
The Imperial Clinical Trials Unit (ICTU) sits within Imperial College London as a department within the School of Public Health in the Faculty of Medicine and brings together academic, clinical and trial management expertise from across the Imperial College Academic Health Science Centre. ICTU also collaborates with members of the designated Academic Health Science Network for North West London – Imperial College Healthcare Partners, other national key clinical and scientific opinion leaders, other CTUs and with industry.
ICTU is a UKCRC registered Clinical Trials Unit recognised for its experience and expertise in the development and delivery of clinical trials and associated high quality clinical research projects across a range of therapeutic areas. The unit leads primarily on the design, conduct and analysis of national and international multi-centre trials and the staff, with specialist disease and methodological knowledge, have input at all stages of the trial lifecycle; thus ensuring all activities are conducted according to the principles of ICH GCP and in compliance with the appropriate regulatory and ethical requirements.
The ICR Clinical Trials and Statistics Unit (ICR-CTSU) is a research-led, academic clinical trials unit (CTU) within the Division of Clinical Studies at the ICR.
ICR-CTSU leads the design, conduct and analysis of phase II and III national and international cancer clinical trials. Our expertise spans the whole clinical trial life cycle and our findings directly influence clinical practice within the NHS and worldwide.
ICR-CTSU clinical trials focus on breast, urological and head and neck cancers, but we also run trials in other rarer cancer types including melanoma, sarcoma and ovarian cancer. We specialise in phase II exploratory and phase III randomised trials of new treatments and technologies (including radiotherapy), and understanding cancer biology and treatment response using biomarker-driven trial designs is fundamental to our research.
We receive core funding from Cancer Research UK, are a UK Clinical Research Collaborative (UKCRC) registered CTU and one of 15 CTUs recognised by the National Cancer Research Institute (NCRI) for professional specialism in the development and delivery of cancer trials.
The LCTC is fully registered within the UKCRC registered CTU network. We are within the Faculty of Health and Life Sciences at the University of Liverpool.
We work with the NHS and commercial partners, patients and the public to contribute to the identification and evaluation of new and innovative treatments and devices.
We have particular expertise in personalised medicine, surgical interventions, and re-purposing of and establishing evidence for existing treatments used within the NHS.
In partnership with other trials methodologists we contribute to the advancement of methods to improve the design and delivery of clinical trials.
We support the development of increased capacity for conducting clinical trials locally and nationally by encouraging the development of clinicians, healthcare professionals, and trials methodologists as leaders in clinical trial research.
In an increasingly complex environment for the development and delivery of clinical trials, the Manchester Clinical Trials Unit (Manchester CTU) is here to provide the expertise you require.
Our expertise
We aim to collaborate and conduct high-quality clinical research that leads to individual and societal benefit.
Our team of over 50 staff have expertise in the design, management, analysis and delivery of multi-centre trials. These studies influence positive developments in clinical practice.
Manchester CTU (formerly MAHSC-CTU) is registered by the UK Clinical Research Collaboration (UKCRC) and receives funding from NIHR, CRUK, The University of Manchester and Health Innovation Manchester.
What is a CTU?
Clinical trials units (CTU) are specialised biomedical research units which design, centrally coordinate and analyse clinical trials and other studies.
The Nottingham Clinical Trials Unit has expertise in the core competencies required for design and conduct of high-quality, high-impact trials: including experienced trialists, trial management, data management and systems programming, statistics, health economics and quality assurance.
We also collaborate with health professionals and researchers to conduct clinical research studies using other research methodologies. For example, conducting extensive scoping work required before a clinical trial is conducted.
In addition to our growing portfolio of clinical trials and other clinical research studies, we design and conduct methodological studies that focus on improving the design and conduct of clinical trials.
Many of our staff are highly experienced in the design and conduct of clinical trials and we therefore offer a training programme of short courses, focusing on providing training to individuals interested in learning how to design and conduct clinical trials.
The UK Trial Managers’ Network (UKTMN) is hosted by us and we also have strong links with other leading groups including the UKCRC-registered Clinical Trials Unit and the MRC-NIHR Trials Methodology Research Partnership.
The Southampton Clinical Trials Unit (SCTU) is a UKCRC registered CTU with expertise in the design, conduct and analysis of multicentre interventional clinical trials. We work in partnership with investigators to deliver high quality trials that will directly influence routine clinical practice.
The York Trials Unit provides a number of services including study design, randomisation, trial coordination, data management, statistics, economic evaluation and outcomes. We also run a number of courses about clinical trials. More information on both historical and currently active trials can be found in the relevant project microsites
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
